is viral hepatitis important world hepatitis day l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Is Viral Hepatitis Important? World Hepatitis Day PowerPoint Presentation
Download Presentation
Is Viral Hepatitis Important? World Hepatitis Day

Loading in 2 Seconds...

play fullscreen
1 / 35

Is Viral Hepatitis Important? World Hepatitis Day - PowerPoint PPT Presentation


  • 579 Views
  • Uploaded on

Is Viral Hepatitis Important? World Hepatitis Day. May 19, 2009 Austin, Texas Gary Heseltine MD MPH Epidemiologist - Infectious Disease Control Unit. Public Health Priorities. World Health Organization Infection control Cancer prevention Office of the Surgeon General Disease prevention

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Is Viral Hepatitis Important? World Hepatitis Day' - Jeffrey


Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
is viral hepatitis important world hepatitis day

Is Viral Hepatitis Important?World Hepatitis Day

May 19, 2009

Austin, Texas

Gary Heseltine MD MPH

Epidemiologist - Infectious Disease Control Unit

public health priorities
Public Health Priorities
  • World Health Organization
    • Infection control
    • Cancer prevention
  • Office of the Surgeon General
    • Disease prevention
    • Eliminating health disparities
  • Association of Schools of Public Health
    • Access to healthcare
    • Eliminating health disparities
    • Disease prevention
hepatitis surveillance what and where
Hepatitis Surveillance: What and Where
  • Acute Hepatitis A (HAV), B (HBV) and C (HCV)
    • Reportable all states*
      • basic information - event date, source of report, demographic characteristics etc.
      • 40% reports to CDC include supplemental information - laboratory test results, clinical information, exposure history etc.
  • Chronic Hepatitis B and C
    • Reportable: HBV 44 states, HCV 42 states
      • Often limited basic information e.g. only a lab report
  • Perinatal Hepatitis B (surface antigen positive pregnant women)
    • Reportable all states (not necessarily separate law)
      • Detailed case management
    • Alaska does not have perinatal B program

*New Hampshire does not report HCV

MMWR March 21, 2008 / Vol. 57 / No. SS-2

slide5

Progression of Liver Disease

Time frame: years to decades

Fibrosis

Cancer

Cirrhosis

BC Hepatitis Services, 2003

slide7

HEPATITIS A RATE, BY AGE AND GENDER

UNITED STATES, 1990

Female

Male

Age

<5

10.1

11.9

5-9

26.7

26.7

10-14

17.7

17.2

15-19

12.8

14.1

20-24

16.1

20.4

25-29

15.8

22.2

30-34

11.4

17.7

35-39

7.9

13.5

40-44

6.4

10.3

45-49

5.6

7.7

50-54

4.4

5.9

55-59

3.8

5.9

60+

2.8

3.4

Rate

slide8

HEPATITIS A RATE, BY AGE AND GENDER

UNITED STATES, 2001

Female

Male

Age

2.2

2.5

<5

4.7

4.7

5-9

3.5

3.6

10-14

2.8

3.4

15-19

3.8

6.3

20-24

3.6

7.5

25-29

2.8

9.3

30-34

2.3

8.7

35-39

2.1

6.1

40-44

2.2

5.6

45-49

2.6

5.2

50-54

2.4

3.6

55-59

2.4

2.8

60+

Rate

hepatitis a post exposure prophylaxis
Hepatitis A Post Exposure Prophylaxis
  • Age 1-40 years, healthy – single dose vaccine
  • Age > 40 years – IG preferred, vaccine OK
  • Age <1 year, immunocompromised, liver disease, vaccine contraindicated - use IG

MMWR Oct. 19, 2007

hav vaccines
HAV Vaccines

EL.U - enzyme-linked immunosorbent assay units

GMT – geometric mean titers

slide11

Geographic Distribution of Hepatitis E

Outbreaks of Confirmed Infection in >25% of Sporadic non-ABC Hepatitis

slide12
HEV
  • 29,000 cases acute viral hepatitis, New Delhi India after sewage contamination drinking water 1955-56
  • Believed to be HAV – retrospective analysis in 1980 yielded enteric NANB
  • 1990’s agent sequenced and called hepatitis E
  • Large outbreaks in tropical and sub-tropical regions
    • Katmandu Valley 1973-74 10,000
    • Kashmir 1978-82 52,000
    • Xinjiang 1986-88 120,000
hev studies
HEV Studies
  • Antibodies to swine HEV cross react with human HEV
  • Prevalence
    • Endemic regions 3 - 26%
      • Saudi Arabia 9.5%, Thailand 2.8%, Egypt 24%
      • Cows, sheep, goats, 40-70% seropositive
    • North America 1- 3%
      • Up to 26% in some studies
      • Unexpectedly high for a non-endemic area
      • Rats 60% seropositive in US
  • Swine HEV ubiquitous in herds, but no illness
  • Belief that HEV is primarily in developing counties - myth
hbv prevalence and genotype distribution 1998
HBV Prevalence and Genotype Distribution 1998

F

D

A

C

A, C, B, D

D

B, C

B

F

E

D

F

A

A, B,C,D

8% and above = High

2% - 8% = Intermediate

G, H not determined

Below 2% = Low

global burden of hepatitis b disease
Global Burden of Hepatitis B Disease

2 billion with markers of current or past infection

350 million chronic carriers

130 million Chinese (1 in 10) have chronic HBV

15%-25% will die from cirrhosis or liver cancer

10th leading cause of death

600,000 to 1 million preventable deaths / year

Second only to tobacco in cause of cancer deaths

Risk of dying from liver cancer 100 greater for carriers than non-carriers

Lavanchy D., J Viral Hepat. 2004 Mar;11(2):97-107.

WHO. www.who.int/csr/disease/hepatitis/en/

slide16
Un homme enceinte s’accouche dans son tombeau*

*A pregnant man delivers in his grave

2006 hbv 4 700 reported cases 46 000 estimated
2006 HBV: 4,700 Reported Cases46,000 estimated

www.cdc.gov/hepatitis/statistics.htm

MMWR March 21, 2008 / Vol. 57 / No. SS-2

Chronicity 5% adults

hbv burden of disease united states
HBV: Burden of Disease United States

200,000 persons infected each year in early 90s

50-60,000 new cases/year (2005)

1 of 20 persons infected with HBV during their lifetime (about 12.5 million)

1 of 200 persons chronic infection with HBV (about 1.25 million), 60% are Asian

2-4,000 deaths each year from cirrhosis, liver cancer

>95% of new infections among adults

MMWR 57: RR-8 2008

are three doses needed
Are Three Doses Needed?

“Thus, protection against chronic carriage does not depend on the number of doses received as originally assumed…results from GHIS follow-up of vaccinated subjects, more than 95% of children that received at least one dose are protected against the acquisition of chronic carriage early in life.”

Fortuin, M. et al Lancet 1993; 341:1129-31

Unapparent exposures as “boosters”?

hcv prevalence and genotype distribution
HCV Prevalence and Genotype Distribution

5

3

1b

1a,b

2

2

6

1a,b

3a

4

1b, 3

5a

2c

hcv 2006 800 reported cases 19 000 estimated
HCV 2006: 800 Reported Cases19,000 Estimated

www.cdc.gov/hepatitis/statistics.htm

Chronicity 70-80% adults

MMWR March 21, 2008 / Vol. 57 / No. SS-2

prevalence of hcv infection by age race and gender united states 1988 1994
Prevalence of HCV Infection by Age, Race, and Gender, United States, 1988-1994

Black females

Black males

White males

White females

Source: NHANES III

reported risk characteristics among adults
Reported Risk Characteristics Among Adults

HCV Recent (<15 yr ago)

HBV Recent (<8 yr ago)

Injection Drug Use

Injection Drug Use

Unknown

Sexual

Other*

MSM

Transfusion

Unknown

Other*

Heterosexual

With shared risk behaviors integrated testing and prevention makes sense.

*Other: Household contact, institutionalization, hemodialysis, occupational exposure etc.

Modified from Sentinel Counties Study of Viral Hepatitis, CDC

surveillance who is missing
Surveillance: Who is missing?
  • Persons with:
    • Lack of signs and symptoms; mild or vague
      • New infections have broad spectrum of presentation
        • Not in provider differential
      • Chronic hepatitis often asymptomatic for years
    • Lack of Access (barriers)
      • Transportation, language, no insurance
      • Marginalized social groups
    • Lack of Trust
      • Disclosure of personal risk factors – sex, drugs
        • Providers don’t ask
      • Legal and law enforcement issues

Outreach is a needed component of a complete surveillance program.

chronic hepatitis burden
Chronic Hepatitis Burden
  • HBV estimated 1.2M persons
    • 50-70% of these persons born outside U.S.
    • 2,000-4,000 deaths per year
  • HCV estimated 3.2-3.7M persons
    • 70% of these persons age 35-54 years
    • 8,000-10,000 deaths per year
    • Elevated ALT, history IDU, and history blood transfusion identified 85% persons 20-59 years
  • Chronic liver disease and cirrhosis 12th leading cause of death nationally, 6th for Hispanics

What proportion of these persons know their sero-status?

Sorrell et al, Ann Int Med, 2009 150(2):104, Armstrong et al , Ann Int Med 2006;144(10):705, www.cdc.gov/hepatitis/

slide28

Other

Hepatitis B

NASH 10%

Hepatitis C 57%

Alcohol 25%

Cause of Newly Diagnosed Chronic Liver Disease

HBV 4.4%

National Cancer Institute – Surveillance Epidemiology and End Results 2006. http://seer.cancer.gov/resources/

Bell et al 2001

slide29
Liver and Intrahepatic Bile Duct Cancer Mortality Rates and Average Annual Deaths by Race and Ethnicity, Texas, 2001-2005

51

391

155

1,242

641

Rates are average annual rates per 100,000 population, age-adjusted to the2000 U.S. Standard Population.

Average annual mortality counts are rounded to the nearest whole.

Source: Texas Cancer Registry, 1995-2005 SeerStat mortality file.

safe injection global network
Safe Injection Global Network

16 billion injections/year / 12 billion syringes sold

33% unsafe in developing countries

12 million HBV infections

3 million HCV infections

120,000 HIV infections

Estimated 1 billion injections for childhood immunizations

Little change until Global Alliance for Vaccine and Immunizations and SIGN were formed

Eligible countries get auto-disable syringes for 3 years

Countries responsible for national plan, training, waste management

Kane A, et al, Bulletin of WHO, 1999, 77:801-807

common mode transmission posttransfusion hepatitis
Common Mode Transmission: Posttransfusion Hepatitis

All volunteer donors

HBsAg

HCV

Donor Screening for HIV Risk Factors

Anti-HIV

3rd gen HBsAg

ALT/Anti-HBc

Anti-HCV

HCV RNA

HBV

hiv hbv hcv chronic infections
HIV, HBV, HCV: Chronic Infections

IVDU

HIV:

1 Million

HCV: 3 million

15-30%

STD

10%

HBV: 1 million

  • HAV: acute infection
    • vaccine

TB-opportunistic

other viruses associated with acute hepatitis
Common in U.S.*

Cytomegalovirus

Epstein-Barr

Herpes simplex

Varicella zoster

Measles

Rubella

Coxsackie

Exotic**

Yellow fever

Argentineanhemorrhagic fever

Bolivian hemorrhagic fever

Lassa fever

Rift Valley fever

Marburg

Ebola

Other Viruses Associated with Acute Hepatitis

* Each causes less than 1% of acute hepatitis. ** Not usually seen in the U.S.

surveillance a better picture
Surveillance: A Better Picture

Immunizations

Regulatory

Vital Statistics

Surveys

Providers

Hospital Discharge Data

Liver Disease Surveillance

Outreach

Workers

Lab Reports

Substance Abuse

TB HIV STD

Hepatitis

Immigrant Health

Perinatal Health